Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

CNS 8Gynecologic 7Breast 6Genitourinary 5Gastrointestinal 5Sarcoma 3Other solid neoplasm 3Other hematologic neoplasm 3Lymphoid 3Head & Neck 3Tumor-Agnostic 1Plasma cell 1Other 1Endocrine 1Dermatologic 1

Conditions

Neoplasms, Plasma Cell 1Lymphoma, Follicular 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Intellectual Disability 1

Interventions

Rituximab 1371Cyclophosphamide 1296Vincristine 662Doxorubicin 583Etoposide 525Prednisone 504Cytarabine 481fludarabine 461Methotrexate 441Dexamethasone 411fludarabine phosphate 396Lenalidomide 347Filgrastim 342Bendamustine Hydrochloride 274Radiotherapy 266venetoclax 254ibrutinib 249Peripheral Blood Stem Cell Transplantation 233Melphalan 229obinutuzumab 227Granulocyte Colony-Stimulating Factor 212Bortezomib 204Gemcitabine 201Busulfan 186Whole-Body Irradiation 185Mycophenolic Acid 174Tacrolimus 164Specimen Handling 161Calcium Dobesilate 150Magnetic Resonance Spectroscopy 149

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Restraint, Physical × Lymphoid × Clear all
NCT05876923 2026-04-09

The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients

Mayo Clinic

Phase NA Recruiting
70 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT04194840 2025-08-05

Transplant Wellness Clinic for Elderly or High Risk Patients Undergoing BMT

Case Comprehensive Cancer Center

Phase NA Completed
20 enrolled
LymphoidPlasma cell

Lymphoma, Neoplasms, Plasma Cell

NCT05900830 2024-11-12

Therapy Program for Academic Skills in Children With Intellectual Disability

Beni-Suef University

Phase NA Completed
20 enrolled
Lymphoid

Lymphoma, Follicular, Intellectual Disability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡